Benzinga | Mar 8, 2021 10:21AM EST

Baxter To Offer Fill/Finish Services To Moderna's COVID-19 Vaccine In US

* Baxter International Inc (NYSE: BAX) has agreed to provide manufacturing services for Moderna Inc's (NASDAQ: MRNA) COVID-19 Vaccine.

* The agreement includes fill/finish sterile manufacturing services and supply packaging for approximately 60-90 million doses of the Moderna COVID-19 Vaccine in 2021.

* Manufacturing facilities located in Bloomington, Indiana, will be used. It employs more than 700 individuals on its 600,000 square-foot campuses.

* Additional details of the agreement were not disclosed.

* Price Action: MRNA shares are trading lower at 1.54% at $130.24 on the last check Monday. BAX shares are up 0.37% at $78.35.